Polar Asset Management Partners Inc. United Therapeutics Corp Transaction History

Polar Asset Management Partners Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$205.95 - $280.43 $1.81 Million - $2.47 Million	-8,800 Reduced 5.97%	138,500 $38.5 Million
Q3 2022 Nov 14, 2022	BUY	$203.3 - $244.17 $13.4 Million - $16.1 Million	65,900 Added 80.96%	147,300 $30.8 Million
Q2 2022 Aug 15, 2022	BUY	$174.81 - $241.14 $3.72 Million - $5.14 Million	21,300 Added 35.44%	81,400 $19.2 Million
Q1 2022 May 16, 2022	SELL	$166.16 - $213.96 $481,864 - $620,484	-2,900 Reduced 4.6%	60,100 $10.8 Million
Q4 2021 Feb 14, 2022	SELL	$184.32 - $216.08 $4.42 Million - $5.19 Million	-24,000 Reduced 27.59%	63,000 $13.6 Million
Q3 2021 Nov 15, 2021	BUY	$179.86 - $214.88 $5.76 Million - $6.88 Million	32,000 Added 58.18%	87,000 $16.1 Million
Q2 2021 Aug 16, 2021	BUY	$170.47 - $211.93 $9.38 Million - $11.7 Million	55,000 New	55,000 $9.87 Million

676

42.1M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.9B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Polar Asset Management Partners Inc., based on Form 13F filings with the SEC.

Stay updated on Polar Asset Management Partners Inc. with notifications on news.